Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by enriquesuave


V.TLT

RE:Money raise coming soon?

Just a hunch, but they have enough $ to keep operating until BTD and...

June 26, 2022

V.TLT

RE:Ph 1b patients #5 and #6 still cancer free after 2 years

Pretty awesome results  I suppose the FDA will see the same level of...

June 22, 2022

V.TLT

RE:RE:N-803 median duration of response

Exactly  N-803 plus BCG is a Combination of 2 drugs ( combo trial...

June 14, 2022

V.TLT

RE:RE:Another $4 Billion Buyout

They received BTD on May 10 and got bought out today for $4.1 Billion  ...

June 3, 2022

V.TLT

Another $4 Billion Buyout

https://endpts.com/bristol-myers-jumps-into-the-ma-game-with-a-4b-oncology...

June 3, 2022

V.TLT

RE:RE:RE:The first 25 Patients

Im not sure if it's 4 or 5 that were dropped but in the September 24 2020...

June 3, 2022

V.TLT

RE:The first 25 Patients

We must not forget that this sample also includes 5 patients from the 1st set...

June 2, 2022

V.TLT

RE:RE:RE:TLT jiggy

I expect news soon on other fronts as Q2 is slated for commencement of animal...

June 1, 2022

V.TLT

BTD

BTD can be applied for early on true, but if granted after fairly substantial...

June 1, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:88% demonstrate that CR at 180 days, 69% at 270 days

Patient # 20 has reached 450 days so patient #1 is like 2+ years.  They...

May 31, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:88% demonstrate that CR at 180 days, 69% at 270 days

Can someone post the chart with the 1st 20 patients?  Since 1st 12 were...

May 30, 2022

V.TLT

RE:RE:RE:RE:RE:88% demonstrate that CR at 180 days, 69% at 270 days

Actually numbers were better for evaluable patients at 180 days (50% CR)vs...

May 30, 2022

V.TLT

RE:88% demonstrate that CR at 180 days, 69% at 270 days

Very good and steady data so far.  Next read out will have more data at...

May 30, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:This constant selling...........

Commercial Revenues in January 2023 could mean a Partnership Deal after BTD...

May 27, 2022

V.TLT

RE:RE:Roger exercised warrants

If there was any chance of insider buying he would be OK excercising warrants...

May 17, 2022

V.TLT

RE:Roger exercised warrants

Roger just excercised 500k shares at 30 cents with $150K of his own money...

May 17, 2022

V.TLT

RE:Final clinical results of N-803 BCG Unresponsive NMIBC Trial

Same results as before.  Very good, but it's also a combination...

May 14, 2022

V.TLT

RE:RE:RE:RE:Pivotal Phase 2 Trial for NSCLC ?

There is no question about it IMO.  Combination immunotherapy has its...

May 11, 2022

V.TLT

RE:RE:Pivotal Phase 2 Trial for NSCLC ?

Roche fails in NSCLC PH3 trial.  They will need Rutherin. https://www...

May 11, 2022

V.TLT

RE:RE:RE:RE:Good news regarding the FDA

I couldn't see anything but you never know?  They will eventually...

May 10, 2022

Featured Company